← FDA DRUG APPROVALS

FDA ANDA · ANDA086156

NITROFURAZONE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA086156
TYPE
ANDA
ORIGINAL APPROVAL
1978-08-15
LATEST ACTION
1992-09-14
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued

Products

NITROFURAZONEDiscontinued
NITROFURAZONE 0.2% · OINTMENT · TOPICAL

Approval history

1992-09-14Labeling · Supplement 21AP
1992-07-28Labeling · Supplement 20AP
1989-08-18Manufacturing (CMC) · Supplement 19AP
1989-05-11Manufacturing (CMC) · Supplement 18AP
1989-05-11Manufacturing (CMC) · Supplement 17AP
1989-02-16Labeling · Supplement 16AP
1986-08-08Manufacturing (CMC) · Supplement 13AP
1985-12-06Manufacturing (CMC) · Supplement 11AP
1985-11-18Manufacturing (CMC) · Supplement 10AP
1984-08-28Manufacturing (CMC) · Supplement 8AP
1982-08-25Manufacturing (CMC) · Supplement 7AP
1982-06-29Manufacturing (CMC) · Supplement 6AP
1978-08-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →